Pharmesis International Ltd. announced unaudited consolidated earnings results for third quarter and nine months ended Sept. 30, 2016. For the quarter, the company reported revenue of RMB 16,593,000, loss from operations of RMB 296,000, loss before tax of RMB 447,000, loss for the period of RMB 447,000, loss attributable to equity holders of the company of RMB 279,000 or 1.21cents basic and diluted per share, net cash flows from operating activities of RMB 1,910,000, acquisition of property, plant and equipment of RMB 184,000, net asset value per ordinary share of RMB 4.1,000 compared to the revenue of RMB 16,014,000, profit from operations of RMB 975,000, profit before tax of RMB 767,000, profit for the period of RMB 767,000, profit attributable to equity holders of the company of RMB 254,000 or 1.27 21cents basic and diluted per share, net cash flows from operating activities of RMB 8,096,000, acquisition of property, plant and equipment of RMB 21,000, net asset value per ordinary share of RMB 4.4,000 for the same quarter a year ago. The Group's revenue increased mainly due to higher revenue from the Group's non-prescribed drugs /distribution segment, offset by lower revenue from prescribed drugs segment. The Group's net cash inflow from operating activities for the third quarter mainly due to cash generated from its operations and changes in working capital. For the year to date, the company reported revenue of RMB 48,181,000, loss from operations of RMB 1,278,000, loss before tax of RMB 1,761,000, loss for the period of RMB 1,770,000, loss attributable to equity holders of the company of RMB 1,829,000 or 7.95 cents basic and diluted per share, net cash flows from operating activities of RMB 1,793,000, acquisition of property, plant and equipment of RMB 513,000, net asset value per ordinary share of RMB 2.66,000 compared to the revenue of RMB 46,064,000, profit from operations of RMB 1,055,000, profit before tax of RMB 1,511,000, profit for the period of RMB 1,511,000, profit attributable to equity holders of the company of RMB 700,000 or 3.5 cents basic and diluted per share, net cash flows from operating activities of RMB 6,445,000, acquisition of property, plant and equipment of RMB 1,423,000, net asset value per ordinary share of RMB 2.93,000 for the same period a year ago.